Identification of the first signs or symptoms in different spondyloarthritis subtypes and their association with HLA-B27: data from REGISPONSER and RESPONDIA registries

Objective To describe and analyse the initial symptoms attributable to patients with spondyloarthritis (SpA) and their association with HLA-B27 status.Methods This was an observational, cross-sectional and multicentre study with patients who fulfilled the European Spondyloarthropathy Study Group cri...

Full description

Bibliographic Details
Main Authors: Jordi Gratacós, Clementina López-Medina, Janitzia Vázquez-Mellado, Eduardo Collantes-Estevez, Alejandro Escudero-Contreras, Xavier Juanola, Pilar Font-Ugalde, María Ángeles Puche-Larrubia, Lourdes Ladehesa-Pineda
Format: Article
Language:English
Published: BMJ Publishing Group 2023-07-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/9/3/e003235.full
_version_ 1797640275696287744
author Jordi Gratacós
Clementina López-Medina
Janitzia Vázquez-Mellado
Eduardo Collantes-Estevez
Alejandro Escudero-Contreras
Xavier Juanola
Pilar Font-Ugalde
María Ángeles Puche-Larrubia
Lourdes Ladehesa-Pineda
author_facet Jordi Gratacós
Clementina López-Medina
Janitzia Vázquez-Mellado
Eduardo Collantes-Estevez
Alejandro Escudero-Contreras
Xavier Juanola
Pilar Font-Ugalde
María Ángeles Puche-Larrubia
Lourdes Ladehesa-Pineda
author_sort Jordi Gratacós
collection DOAJ
description Objective To describe and analyse the initial symptoms attributable to patients with spondyloarthritis (SpA) and their association with HLA-B27 status.Methods This was an observational, cross-sectional and multicentre study with patients who fulfilled the European Spondyloarthropathy Study Group criteria for SpA from the Registry of Spondyloarthritis of Spanish Rheumatology (REGISPONSER) and Ibero-American Registry of Spondyloarthropathies (RESPONDIA) united registries. Differences in the first sign(s) or symptom(s) were compared across diagnoses and between HLA-B27 status. The diagnostic delay between patients who start the disease with musculoskeletal manifestations (MMs) and extra-MMs (EMMs) was compared.Results A total of 4067 patients were included (2208 from REGISPONSER and 1859 from RESPONDIA) (ankylosing spondylitis (AS): 68.3%, psoriatic arthritis (PsA): 19.9%, undifferentiated SpA: 11.8%). Overall, 3624 (89.1%) patients initiated the disease with MMs and 443 (10.9%) with EMMs. Low back pain (61.7%) and lower-limb arthritis (38.5%) were the most frequent initial symptoms. In AS patients, the absence of HLA-B27 seems to be related to an increase in the probability of starting the disease with cervical pain and peripheral manifestations. In PsA, the onset of arthritis and psoriasis was more prevalent in HLA-B27-negative patients, while initiation with axial manifestations was more predominant in HLA-B27-positive patients. The diagnostic delay was longer in patients with initial MMs than in those with EMMs (7.2 (34.8) vs 4.5 (7.6) years, respectively).Conclusion In this SpA population, MMs were the most prevalent initial symptoms, with differences across diagnoses and depending on the presence of the HLA-B27 antigen.
first_indexed 2024-03-11T13:29:33Z
format Article
id doaj.art-85921cbeb4c44521850d6724aab214d1
institution Directory Open Access Journal
issn 2056-5933
language English
last_indexed 2024-03-11T13:29:33Z
publishDate 2023-07-01
publisher BMJ Publishing Group
record_format Article
series RMD Open
spelling doaj.art-85921cbeb4c44521850d6724aab214d12023-11-03T03:20:08ZengBMJ Publishing GroupRMD Open2056-59332023-07-019310.1136/rmdopen-2023-003235Identification of the first signs or symptoms in different spondyloarthritis subtypes and their association with HLA-B27: data from REGISPONSER and RESPONDIA registriesJordi Gratacós0Clementina López-Medina1Janitzia Vázquez-Mellado2Eduardo Collantes-Estevez3Alejandro Escudero-Contreras4Xavier Juanola5Pilar Font-Ugalde6María Ángeles Puche-Larrubia7Lourdes Ladehesa-Pineda8Department of Rheumatology, Hospital Universitario Parc Taulí, Barcelona, SpainDepartment of Rheumatology, Reina Sofia University Hospital, Cordoba, SpainDepartment of Rheumatology, Hospital General de Mexico, Mexico City, MexicoGC-05 Group, Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Cordoba, SpainMedical and Surgical Sciences, University of Cordoba, Cordoba, SpainDepartment of Rheumatology, Hospital Universitari de Bellvitge, Barcelona, SpainGC-05 Group, Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Cordoba, SpainDepartment of Rheumatology, Reina Sofia University Hospital, Cordoba, SpainDepartment of Rheumatology, Reina Sofia University Hospital, Cordoba, SpainObjective To describe and analyse the initial symptoms attributable to patients with spondyloarthritis (SpA) and their association with HLA-B27 status.Methods This was an observational, cross-sectional and multicentre study with patients who fulfilled the European Spondyloarthropathy Study Group criteria for SpA from the Registry of Spondyloarthritis of Spanish Rheumatology (REGISPONSER) and Ibero-American Registry of Spondyloarthropathies (RESPONDIA) united registries. Differences in the first sign(s) or symptom(s) were compared across diagnoses and between HLA-B27 status. The diagnostic delay between patients who start the disease with musculoskeletal manifestations (MMs) and extra-MMs (EMMs) was compared.Results A total of 4067 patients were included (2208 from REGISPONSER and 1859 from RESPONDIA) (ankylosing spondylitis (AS): 68.3%, psoriatic arthritis (PsA): 19.9%, undifferentiated SpA: 11.8%). Overall, 3624 (89.1%) patients initiated the disease with MMs and 443 (10.9%) with EMMs. Low back pain (61.7%) and lower-limb arthritis (38.5%) were the most frequent initial symptoms. In AS patients, the absence of HLA-B27 seems to be related to an increase in the probability of starting the disease with cervical pain and peripheral manifestations. In PsA, the onset of arthritis and psoriasis was more prevalent in HLA-B27-negative patients, while initiation with axial manifestations was more predominant in HLA-B27-positive patients. The diagnostic delay was longer in patients with initial MMs than in those with EMMs (7.2 (34.8) vs 4.5 (7.6) years, respectively).Conclusion In this SpA population, MMs were the most prevalent initial symptoms, with differences across diagnoses and depending on the presence of the HLA-B27 antigen.https://rmdopen.bmj.com/content/9/3/e003235.full
spellingShingle Jordi Gratacós
Clementina López-Medina
Janitzia Vázquez-Mellado
Eduardo Collantes-Estevez
Alejandro Escudero-Contreras
Xavier Juanola
Pilar Font-Ugalde
María Ángeles Puche-Larrubia
Lourdes Ladehesa-Pineda
Identification of the first signs or symptoms in different spondyloarthritis subtypes and their association with HLA-B27: data from REGISPONSER and RESPONDIA registries
RMD Open
title Identification of the first signs or symptoms in different spondyloarthritis subtypes and their association with HLA-B27: data from REGISPONSER and RESPONDIA registries
title_full Identification of the first signs or symptoms in different spondyloarthritis subtypes and their association with HLA-B27: data from REGISPONSER and RESPONDIA registries
title_fullStr Identification of the first signs or symptoms in different spondyloarthritis subtypes and their association with HLA-B27: data from REGISPONSER and RESPONDIA registries
title_full_unstemmed Identification of the first signs or symptoms in different spondyloarthritis subtypes and their association with HLA-B27: data from REGISPONSER and RESPONDIA registries
title_short Identification of the first signs or symptoms in different spondyloarthritis subtypes and their association with HLA-B27: data from REGISPONSER and RESPONDIA registries
title_sort identification of the first signs or symptoms in different spondyloarthritis subtypes and their association with hla b27 data from regisponser and respondia registries
url https://rmdopen.bmj.com/content/9/3/e003235.full
work_keys_str_mv AT jordigratacos identificationofthefirstsignsorsymptomsindifferentspondyloarthritissubtypesandtheirassociationwithhlab27datafromregisponserandrespondiaregistries
AT clementinalopezmedina identificationofthefirstsignsorsymptomsindifferentspondyloarthritissubtypesandtheirassociationwithhlab27datafromregisponserandrespondiaregistries
AT janitziavazquezmellado identificationofthefirstsignsorsymptomsindifferentspondyloarthritissubtypesandtheirassociationwithhlab27datafromregisponserandrespondiaregistries
AT eduardocollantesestevez identificationofthefirstsignsorsymptomsindifferentspondyloarthritissubtypesandtheirassociationwithhlab27datafromregisponserandrespondiaregistries
AT alejandroescuderocontreras identificationofthefirstsignsorsymptomsindifferentspondyloarthritissubtypesandtheirassociationwithhlab27datafromregisponserandrespondiaregistries
AT xavierjuanola identificationofthefirstsignsorsymptomsindifferentspondyloarthritissubtypesandtheirassociationwithhlab27datafromregisponserandrespondiaregistries
AT pilarfontugalde identificationofthefirstsignsorsymptomsindifferentspondyloarthritissubtypesandtheirassociationwithhlab27datafromregisponserandrespondiaregistries
AT mariaangelespuchelarrubia identificationofthefirstsignsorsymptomsindifferentspondyloarthritissubtypesandtheirassociationwithhlab27datafromregisponserandrespondiaregistries
AT lourdesladehesapineda identificationofthefirstsignsorsymptomsindifferentspondyloarthritissubtypesandtheirassociationwithhlab27datafromregisponserandrespondiaregistries